The nation of Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (£272m) spanning five years due to Washington's insistence on confidential information.
This move was revealed following a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
An official representative later explained that the United States was demanding access to health data for scientific study and profit but was not willing to guarantee the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for continued negotiations to reach a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.
Wider Background
Zimbabwe's decision comes after a similar situation in Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the safety of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral agreements to enhance openness and accountability.
Based on statements, Sixteen nations in Africa have so far signed these new agreements, representing over $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration could have provided significant advantages for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment via American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, with no corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Put simply, our nation would supply the basic resources for medical research with no certainty that the end products would be accessible to our people if a new pandemic emerge."
Sovereignty and Global Health
He also said that the American exit from the global health body and its push of one-on-one deals were disrupting frameworks already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.
"This system is designed to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future co-operation could be arranged in a manner that honours the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but recommended that negotiations must proceed given that much of the nation's Aids initiatives were funded by international support.
"If specific concerns arise, such as those involving information security or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," the group added.
This impasse emphasises the complex challenges between accepting much-needed international aid and safeguarding local interests in an increasingly interconnected world.